FIELD: medicine.
SUBSTANCE: invention is intended for gastroparesis treatment in women. Composition based on metoclopramide or on a pharmaceutically acceptable salt thereof, is administered intranasally.
EFFECT: method allows to reduce the gastroparesis associated symptoms in women.
20 cl, 4 dwg, 9 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS | 2013 |
|
RU2652352C2 |
| INTRANASAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF | 2012 |
|
RU2692245C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF VASOMOTOR SYMPTOMS | 2018 |
|
RU2815402C2 |
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
| NEW AUXILIARY THERAPY FOR USE IN THE TREATMENT OF PROSTATE CANCER | 2018 |
|
RU2758386C2 |
| ESKETAMINE FOR TREATING DEPRESSION | 2018 |
|
RU2822657C2 |
| METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING IL-4R ANTAGONIST | 2014 |
|
RU2674680C2 |
| INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE | 2012 |
|
RU2587051C2 |
